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Agricultural pesticide use has been repeatedly, 
but not consistently, associated with risk of 
non-Hodgkin’s lymphoma (NHL; Blair et al., 
1992;  Dreiher  and  Kordysh,  2006).  Over   
the past years, it has become clear that NHL 
heterogeneity is setting many hurdles to this 
connection  and  that  pertinent  biomarkers 
must  be  identified  according  to  malignant   
subtypes (Harris et al., 1994). Among those, 
t(14;18) translocation constitute the genetic 
hallmark and early initiating event of follicu-
lar lymphoma (FL), a germinal center (GC)–
derived malignancy representing one of the 
most common adult NHLs (Cleary et al., 1986; 
Kuppers, 2005). However, the t(14;18) is also 
present in the peripheral blood of a significant 
proportion of healthy individuals (HI; Limpens 
et al., 1995; Dolken et al., 1996; Roulland   
et  al.,  2003).  Although  the  significance  of 
t(14;18) in blood from HI is as yet unclear, 
we have previously reported trends to higher 
t(14;18) prevalence among farmers occupa-
tionally exposed to pesticides (Roulland et al., 
2004). Since then, recent epidemiological data 
have  established  that  pesticide  exposure  is 
strongly associated with the risk of t(14;18)+ 
NHL  development  but  not  with  t(14;18)-
negative cases, suggesting that pesticides may act 
through a t(14;18)-dependant pathway (Chiu 
et al., 2006). Nonetheless, a direct mechanis-
tic link between environmental exposure and 
the t(14;18) during FL pathogenesis remains to 
be conclusively demonstrated. Because secur-
ing this correlation between a biomarker of risk 
and a carcinogen exposure could have major 
impact on cancer prevention and public health, 
we sought to determine the molecular links of 
this connection.
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The t(14;18) translocation constitutes the initiating event of a causative cascade leading 
to follicular lymphoma (FL). t(14;18) translocations are present in blood from healthy 
individuals, but there is a trend of increased prevalence in farmers exposed to pesticides, a 
group recently associated with higher risk of t(14;18)+ non-Hodgkin’s lymphoma develop-
ment. A direct connection between agricultural pesticide use, t(14;18) in blood, and 
malignant progression, however, has not yet been demonstrated. We followed t(14;18) 
clonal evolution over 9 yr in a cohort of farmers exposed to pesticides. We show that 
exposed individuals bear particularly high t(14;18) frequencies in blood because of a 
dramatic clonal expansion of activated t(14;18)+ B cells. We further demonstrate that 
such t(14;18)+ clones recapitulate the hallmark features of developmentally blocked FL 
cells, with some displaying aberrant activation-induced cytidine deaminase activity linked 
to malignant progression. Collectively, our data establish that expanded t(14;18)+ clones 
constitute bona fide precursors at various stages of FL development, and provide a  
molecular connection between agricultural pesticide exposure, t(14;18) frequency in 
blood, and clonal progression.
© 2009 Agopian et al.  This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.jem.org/misc/terms.shtml). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial– 
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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area (the “control” population) was similarly followed, as de-
tailed previously (Roulland et al., 2003; Roulland et al., 2004).
The evolution of t(14;18) frequency was followed over 
9 yr in both cohorts. Strikingly, although t(14;18) frequency 
slowly increased in the control population (+87%; P = 0.03), 
mostly as the result of aging (Roulland et al., 2006a), a dra-
matic increase was observed for the exposed cohort (+253%; 
P < 0.0001 using the paired t test; Fig. 1 A). Contrary to 
RESULTS And dISCUSSIOn
To address this issue, we used a prospective agricultural cohort 
representing a total of 753 individuals, including adult family 
members living/working on a farm. We performed a longitu-
dinal cohort study in a sample of 128 farmers from this cohort 
defined as pesticide users on crops at enrollment (the “exposed” 
population). As a reference, an independent cohort of 25 
unexposed nonfarmers recruited from the same geographical 
Figure 1.  Agricultural exposure drives a dramatic increase of t(14;18)+ clones in blood. (A) Evolution of t(14;18) frequency in PBMCs from 
control and exposed populations over time. The mean age at enrollment was 40 yr (±9 yr) for the controls and 43 yr (±9 yr) for the exposed individu-
als, with an average follow-up time of 7 and 9 yr, respectively. t(14;18) frequency was assessed at each time point by fluctuation SR-PCR. Horizontal 
lines indicate mean frequencies. p-values were calculated using the Mann-Whitney test. (B) Clonality analysis. Exposed (n = 26/51, 51%) and control 
(n = 6/46, 13%) samples with a high t(14;18) frequency (>105) in the last sampling period are shown and ordered according to increasing t(14;18) 
frequencies (the total number of clones in each individual for which more than one positive amplicon was found is summarized in Table S1). BCL2/JH 
breakpoints (Table I and unpublished data) were identified by the cloning/sequencing of SR-PCR products (n ≈ 1,000) amplified from PBMCs, and were 
used to monitor the extent of polyclonality within t(14;18)+ cells in each individual. For each individual, independent BCL2/JH clones are pictured in 
distinct shades and are represented from bottom to top according to increasing frequency.JEM VOL. 206, July 6, 2009  1475
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Table I.  Phenotypic and genotypic characterization of BCL2/IGH junctions in isolated B cell subsets from both exposed and 
control HI
  B cell subsets PCRa RAG-mediated activity AID-mediated 
activity
GC 
transitb
  IgDc CD10 CD27d Nb clones BCL2-mbr (5 to 3)e N nucleotides (5 to 3) JH CSR SHMf Rate 
(%)
Exposedg
  78 + +  SR (1) CAGTGGTGCT 
 TACGCTCCACCA
CCCCTGAGGCAGAT J6 n.a. n.a. – –
  n.d. + + SR(3)/LR(1) AAGAAAGCAGGAAe GAACGTTACCTCAGGGG 
  ACTTCCCCGCGCCCCCCG
J6 1 9/821 10.9 yes
  + +  SR (1) CAGACCTCCCCCGGC  J6 n.a. n.a. –
  +  + LR (1) CAGTGGTG 
 CTTACGCTCC
TTCGGGTGTGATCGGTCGG J6  3/1,262 2.4 yes
  +  + LR (1) AAGAAAGCAGGAAe GAACGTTACCTCAGGGG 
  ACTTCCCCGCGCCCCCCG
J6 1 8/821 9.8 yes
  +  + LR (1)  CAGTGGTG TTGTAGTAGGAAA J6  1/1,262 0.8 yes
  +  + LR (1) CAGTGGTG TTGTAGTAGGAAA J6 1 1/474 2.1 yes
 
  138 + +  SR (1) CAGTGGTGCTTACGCT ATCGCGACGGGCTA J3-6 n.a. n.a.
  +   LR (1) ACAAGTCCTTTA (*ICR) GATCGGGGTCCCCCCGGGA J6b 2 4/900 4.4 yes
  +/h  + LR (3) CAGACCTC  TTGTGAGGGGCCATGGTTA 
  TCCCAGGACGTCGTCGCCGA
J6b 1 44/4,176 10.5 yes
 
  326 + +  SR (1) CAGTGGe ATACTTGGGACAG J4 n.a. n.a. –
  + +  SR (1) CAGTGGTGCTTA TCAGGTAGGGGG J6 n.a. n.a. –
    + LR (1) CAGTGGe ATACTTGGGACAG J4 1 1/687 1.5 yes
  +  + LR (2) CCTCCTGCCCTCC GGTAGACTAGACCC J4  6/2,524 2.4 yes
 
  431 + +  SR(7)/LR(2) CAGTGGTGCTTAe AATTTAGTCT J6  6/2,524 2.4 yes
  +  + LR (2) CAGTGGTGCTTAe AATTTAGTCT J6  3/2,276 1.3 yes
 
  433 + +  SR (1) CAGACCT 
 CCCCCGGCGG
TTTTTCGAAGACGATATCAGGGT J6 n.a. n.a. –
  +  + LR (1) CAGACCTCCCCC CCGAGCG J4  10/753 13.5 yes
 
  576 +/  + LR (3) CCTCCTGCCCTC GTACGATTTTTGGAGTGGTCT J6  4/2,046 1.9 yes
 
  605 + +  SR (1) CCTCCTGCCCTCCTTCe GGGTTTACTCCCCGGGTTTT J5 n.a. n.a. –
  +/ + + SR(1)/LR(1)  TGCTTTACGT TGCTC J6  1/1,262 0.8 yes
  + + + SR (1) AAGAAAGCAGGAe CCCCCACGGAG J6 n.a. n.a. yes
  + +  LR (1) TCAGGGAACAGAA CCCCTAGATAGTGGGAGCTCCAT J6b  0/1,262 0 –
    + LR (1) CAGTGGTGCTTA AGGAAGAAGTCG J4  2/1,262 1.6 yes
  +  + LR (1) AAGAAAGCAGGAe CCCCCACGGAG J6  n.d. n.d. yes
  +  + LR (1) CCTCCTGCCCTCCTTCCe TCGAGAGAAG J5  5/1,262 4 yes
 
  611 + +  LR (3) CAGTGGTGCe CGAATGG J6  20/3,500 5.7 yes
  n.d. + + SR (3) CAGACCTCCCCCGGe TTAGAGTTTGTGGGGCCCGTTGGGACG J6 n.a. n.a. yes
  n.d. + + SR (1) CAGTGGTGCTTACG TGCCGACCAAA J3 n.a. n.a. yes
  + +  SR (2) AAGAAAGCAG AGGGCCCCACCCTG J6 n.a. n.a. –
  n.d. + + SR (4) AAGAAAGCA AGGCAGGGCTTCGAGGG J6 n.a. n.a. yes
  +/  
 +/
  
   
+  
   +
LR (4)  
LR (3)
CAGTGGTGCe  
 CAGTGGTGCe
CGAATGG  
  CGAATGG
J6  
 J6
  
  1
21/5,048  
2/95
4.2  
 –i
yes  
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Table I.  Phenotypic and genotypic characterization of BCL2/IGH junctions in isolated B cell subsets from both exposed and 
control HI (Continued)
  B cell subsets PCRa RAG-mediated activity AID-mediated 
activity
GC 
transitb
  IgDc CD10 CD27d Nb clones BCL2-mbr (5 to 3)e N nucleotides (5 to 3) JH CSR SHMf Rate 
(%)
    + LR (1) CAGACCTCCCCCGGe TTAGAGTTTGTGGGGCCCGTTGGGACG J6 3 23/1,109 20.7 yes
  + LR (1) CAGACCTCCC GAGATAGGGTTCAGGGGC J6 3 11/667 16.5 yes
+  + LR (1) CAGTGGTGCTTAC CGCCCTAGCTGC J6 1 7/857 8.1 yes
Anonymous 
blood 
donorsf
  33 n.d. + n.d. LR (1) CTTTACGTGGCCTe TAGTACCAGCTGCCCCCTA J6  n.d. n.d. –
n.d. + n.d. SR (3) CAGTGGTGCe CAGCTGCCCCCCCCCGCCT 
  GGCGGTGGGTTGTGCGGCCCC
J1 n.a. n.a. –
n.d. + n.d. LR (1) CAGTGGTGC CCTCGCCATATGTTC 
  GTAACCCCGTCACCACC
J6 3 2/521 3.8 yes
n.d.  + SR (1) CTTTACGTGGCCTe TAGTACCAGCTGCCCCCTA J6 n.a. n.a. yes
n.d.  + SR (7) CAGTGGTGCe CAGCTGCCCCCCCCCGCCT 
  GGCGGTGGGTTGTGCGGCCCC
J1 n.a. n.a. yes
n.d.  + SR(13)/
LR(3)
CAGTGG GGGT J6  5/1,262 4 yes
  37 n.d. + n.d. LR (1) CCTCCTGCCCTCCTT AAACCA J4  13/1,282 11.1 yes
n.d. + n.d. SR(5)/LR 
(1)
CCTCCTGCCCTCCTTCCe CCTTGGGGGGCT J6  3/1,448 2 yes
n.d. + n.d. SR (1) CAGTGGTGCTTe GATTAGAGG J5 n.a. n.a. –
n.d. + n.d. LR (1) CAGACCTCCCCGe AGAACCCCGCATAAA J6  1/1,526 0.7 –
n.d.  + SR(4)/LR 
(1)
CCTCCTGCCCTCCTTCCe CCTTGGGGGGCT J6  8/2,793 2.9 yes
n.d.  + SR(1)/LR 
(1)
CAGTGGTGCTTe GATTAGAGG J5  2/2,966 0.7 yes
n.d.  + SR (4) CAGACCTCCCCGe AGAACCCCGCATAAA J6 n.a. n.a. yes
Controlsf
  118 + n.d. + LR (1) CTCCTTCCGCGGG A J4  5/2,620 1.9 yes
+ n.d. + LR (1) CAGTGGTGCTTA GTGAATAGCGGGGCTC J3  3/1,262 2.4 yes
  92 + n.d. + LR (1) GCTTTCTCATGG TTCTTTTTCGGTAGGGTTGAGCACG J5  0/1,262 0 yes
LR (1) CAGTGGTGCTTAC TGACCTCGGTCGA J4  2/1,262 1.6
  111 + n.d. + LR (2) CAGTGGT TTCTTTCGGGG-(DH3-9/DH3-10)-GTTAGG J5  17/2,524 6.8 yes
  100 + n.d. + LR (1) CAGTGGTG GATATTTTCGGGGGCAACG 
  ACCGGGAGGATTGTCTCAAAA
J4  1/1,262 0.8 yes
  103 + n.d. + LR (1) CAGACCTCCCCGGC CCCCCCCCAGAA J6  2/1,262 1.5 yes
LR (4) CAGACCTCCCCGGC CCCCCCCCAGAA J6 1 7/5,048 1.4 yes
  102 + n.d. + LR (4) CCTCCTGCCCTCCTTCCG TTCCTGTCCAAAAAG J6  5/5,048 0.9 yes
+ n.d. + LR (1) CAGACCTCCCCGGC TGGGTTAGG J5 1 3/645 4.6 yes
 n.d. + LR (1) CCTCCTGCC 
CTCCTTCCGCGG
CCGTTGTGGGGACTCA J6  5/1,262 4 yes
  127 + n.d. + LR (2) CAGACCTCCCCGG TATCGCTAAACACGAT J6 2 20/1,932 10.3 yes
 n.d. + LR (3) CAGACCTCCCCGG TATCGCTAAACACGAT J6 2 110/7,329 15 yes
 n.d. + LR (3) CAGTGGTGCTTA AGGTGGTC J6 1 n.d. n.d. yes
n.a., not applicable; n.d., not determined.JEM VOL. 206, July 6, 2009  1477
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Table I.  Phenotypic and genotypic characterization of BCL2/IGH junctions in isolated B cell subsets from both exposed and 
control HI (Continued)
controls, neither age nor aging effects were found in the 
exposed cohort at enrollment or follow up (P = 0.8 or 0.47, 
respectively, using the Spearman rank test). However, the 
relation with age was restored in farmers who stopped all 
agricultural activity (P = 0.05 using the Spearman rank test; 
Fig. S1). Collectively, our data firmly establish that cumulative 
agricultural pesticide exposure is associated with a dramatic 
increase of t(14;18) frequency in blood.
We next sought to define how environmental exposure 
might  be  causally  connected  to  this  increase.  Pesticides   
are often regarded as genotoxic chemicals generating DNA 
breaks, thereby favoring the accumulation of chromosomal 
translocations  (Garry  et  al.,  1996).  We  thus  monitored   
the extent of polyclonality of t(14;18) breaks by analyzing 
BCL2/JH junctions. Surprisingly, although some exposed 
individuals  indeed  displayed  an  unusual  accumulation  of 
distinct t(14;18) translocations, most individuals carried one 
to two dominant clones (Fig. 1 B and Table S1). Further-
more, upon cell sorting of the peripheral B cell subsets, 
most clones displayed markers of GC transit: sCD27 and/or 
class switch recombination (CSR)/somatic hypermutation 
(SHM; Klein and Dalla-Favera, 2008), including the previ-
ously described “allelic paradox” (Roulland et al., 2006b) 
that stands as a hallmark of FL (simultaneous presence of 
sIgM+D+ on the productive allele and of CSR on the non-
functional allele; Table I; and Figs. S2 and S3). Note that 
the presence of this allelic paradox is in sharp contrast with 
the features of the peripheral IgM+IgD+CD27+ B cell subset 
(being devoid of CSR both on the productive and the 
nonproductive alleles), and adds to the evidence of GC-
expanded clones, distinct from a putative marginal zone   
B cell origin (Weller et al., 2004; Roulland et al., 2006b). 
This indicates that the t(14;18) increase observed in exposed 
farmers results far more from an immunogenic effect of 
agricultural  pesticide  exposure,  leading  to  an  extensive   
clonal expansion of activated t(14;18)+ B cells, than from   
a genotoxic effect. Importantly, expansions of activated 
t(14;18)+ B clones (>105) could also be observed among a 
few control individuals (Fig. 1 B and Table I). Although the 
expansions were more moderate, this suggests that a com-
plex set of environmental factors (possibly including infec-
tious agents such as the hepatitis C virus) can give rise to the 
activation  of  t(14;18)+  B  clones  (Giannelli  et  al.,  2003; 
Roulland et al., 2008), with agricultural pesticide exposure 
provoking a particularly pronounced immunogenic effect.
Is this clonal expansion of activated t(14;18)+ cells con-
nected to a high risk of malignant transformation? Upon anti-
gen encounter, normal activated B cells reach the GCs, where 
the activation-induced cytidine deaminase (AID)–mediated 
program of affinity maturation randomly modifies their re-
ceptors through CSR and SHM (Muramatsu et al., 2000). 
In the vast majority of cases, this process leads to a decrease in 
receptor affinity and B cells die by neglect in situ. In FL, 
three successive steps lay out the lymphomagenesis path-
way: (a) t(14;18)-enforced ectopic expression of BCL2 in GC-
activated B cells, leading to their illegitimate rescue from cell 
death (McDonnell et al., 1989; Kuppers, 2005; Klein and 
Dalla-Favera, 2008); (b) consequent maturation arrest and   
accumulation as centrocyte/centroblast-like cells with on-
going AID activity (Aarts et al., 2000; Smit et al., 2003); and 
(c) consequent accumulation of complementary oncogenic hits, 
partly because of AID-mediated genomic instability (Ramiro 
et al., 2006; Bende et al., 2007; Pasqualucci et al., 2008). We 
thus sought to determine where the activated t(14;18)+ B cells 
stood in this cascade of events leading to FL genesis.
Although t(14;18) carried by HI are morphologically un-
distinguishable from those found in FL tumors (Dolken et al., 
1996; Jager et al., 2000; Roulland et al., 2006b), the expres-
sion of BCL2/IGH fusion transcripts (Cleary et al., 1986; 
Seto et al., 1988) has to date never been functionally demon-
strated in HI, partly because of the experimentally challeng-
ing issue of detecting transcripts at such low frequencies. We 
thus set up a sensitive RT-PCR assay (Fig. S4) and studied a 
set of control (n = 15) and exposed (n = 32) individuals with 
low (<105) or high (>105) frequencies (Fig. 2 A, triangles). 
BCL2/IGH  quantification  clearly  shows  that  transcription 
levels closely parallel translocation frequencies (Fig. 2 A, his-
tograms). Furthermore, in purified B cell subsets from a given 
individual, only t(14;18)-positive fractions allowed BCL2/
IGH detection (Fig. S5). We next assessed how BCL2/IGH 
transcription levels compared with those in FL patients. 
To account for the large difference in t(14;18) frequency 
between FL and HI (Fig. 2 B, triangles), we calculated a nor-
malized ratio of transcription level per t(14;18)+ cell. Our 
data clearly show that BCL2/IGH expression is comparable 
in the t(14;18)+ cells of FL and HI (Fig. 2 B, histograms). 
aType of PCR assay in which the fragment was obtained (number of positive amplicons of the given immunogeno-/phenotype; Fig. S6 B).
bBased on CD27+ and/or CSR+ and/or SHM+.
cSee Fig. S3 for evaluation of the IgM status.
dCD27 is a pertinent GC marker only when present, as the loss/absence of CD27 after GC transit has been shown to occur in recently identified memory B cell subsets 
(Ehrhardt et al., 2005; Wirths and Lanzavecchia, 2005; Tangye and Good, 2007) and is variably expressed on FL cells.
eBCL2/JH junctions detected in both CD10+ and CD10 fractions.
fSHM corresponds to the number of somatic mutations/total length of Sµ analyzed (bp). Background mutation levels were calculated to be 0.55‰ (Fig. S2 A).
gSorted according to CD10, CD27, and IgD for exposed samples (Fig. S6 A, top); according to CD10 and CD27 into CD10+ and CD10CD27+ for anonymous blood donors  
(Fig. S6 A, bottom); and according to CD27 and IgD for controls (only the CD27+ is shown). Eight additional anonymous blood donors were screened and excluded from the 
analysis due to the absence of the t(14;18) detection.
h+/ indicates PCR fragments detected in both positive and negative sorted B cell fractions.
iThe mutation rate was not estimated due to the partial deletion of the Sµ region.1478 AGRICULTURAL EXPOSURE IS LINKED TO T(14;18) LYMPHOMAGENESIS | Agopian et al.
blast-like cells, CD10+ and CD10 cell populations were 
sorted (Fig. S6 A). In all individuals, t(14;18) could be found 
in both the CD10+ and CD10 subsets (50 vs. 66 amplicons, 
respectively; Table I and Fig. S6 C). In most cases, CD10+ 
and CD10 clones (with identical BCL2/IGH) coexisted in 
peripheral blood after GC transit (Table I, note e). This indi-
cates that similar to FL patients, at least a fraction of the 
circulating t(14;18)+ cells from HI also retained the CD10 
marker normally lost upon GC exit (Kuppers, 2005). One 
additional seminal feature of FL tumor cells that stands as a 
direct consequence of their status as frozen GC B cells is the 
sustained AID expression (Smit et al., 2003; Bende et al., 
2007), normally down-regulated upon GC exit. We thus 
Collectively, these findings demonstrate that similar to tumor 
cells in FL patients (Seto et al., 1988), t(14;18)+ cells in HI 
are actively transcribing BCL2 from the translocated allele, 
allowing their rescue from apoptosis in the GCs.
Malignant  FL  cells  are  frequently  released  from  the 
founder follicle to the bloodstream, and undergo extensive 
trafficking between organs, thereby favoring tumor dissemi-
nation (Oeschger et al., 2002). However, consistent with 
their status as frozen centrocyte/centroblast-like cells, most 
nodal and at least a fraction of circulating FL tumor cells 
retain some GC markers such as CD10 (CD10+/, REAL 
classification; Harris et al., 1994). To determine if t(14;18)+ 
clones from HI also represent released centrocyte/centro-
Figure 2.  t(14;18)+ cells in HI are actively transcribing BCL2 from the translocated allele. (A) Superposition of t(14;18) frequency (triangles; 
left y axis) and the relative BCL2/JH expression levels (histograms; right y axis) in PBMC samples from controls (n = 15) and exposed individuals (n = 32) 
evaluated by real-time quantitative PCR. The absolute BCL2/JH expression data were normalized to ABL, and the value is arbitrarily set as ×100,000. 
Each bar represents the mean of replicate wells. The results shown were obtained from two independent PCRs performed in duplicate (B) BCL2/JH  
expression levels in FL biopsies (n = 12) compared with samples from HI (n = 18) with respect to their t(14;18) frequency. A normalized ratio of BCL2 
expression per t(14;18)+ cell was calculated by dividing the normalized BCL2/JH transcription level of a given sample by the corresponding t(14;18) 
frequency (as determined by real-time PCR).JEM VOL. 206, July 6, 2009  1479
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expansion, identical clones (in terms of CSR and SHM) should 
be generated, whereas if AID were on, clonal expansion 
should lead to a population of clonal SHM/CSR variants. 
We thus obtained large blood samples from control (n = 7) 
and exposed (n = 8) individuals, and analyzed switched ver-
sus unswitched purified B cell subsets for both SHM and 
CSR events on the translocated allele (Fig. S6 B). For most 
BCL2/IGH clones issued from clonal expansions, we were 
able to build genealogical trees based on intraclonal variation 
(ICV) of the Sµ region on the translocated allele (Nagaoka et al., 
2002), taking into account both CSR and SHM (Fig. 4). Strik-
ingly, the vast majority of subclones displayed ICV: out of 69 
amplicons (and despite the fact that the expected rate of SHM 
is much lower in the Sµ region than in the IgVH region), 
only 2 were found to be strictly identical (case #103, B1/B2). 
first attempted to evaluate AID expression in t(14;18)+ cells. 
Because AID transcripts are not different in translocated and 
normal cells, we sought to assess an expression difference of 
AID between individuals with low (<105) and high (>105) 
t(14;18) frequencies. Results show that detection of AID 
expression in total PBMCs correlates remarkably well with 
increasing t(14;18)+ frequencies (Fig. 3 A, shaded histograms). 
Moreover, AID levels could be enriched through fractionat-
ing total blood into t(14;18)-positive B cell subsets (Fig. 3 B). 
A similar tendency (but less significant because of high back-
ground levels; Ye et al., 1997) was observed with BCL6 
(Fig. S7). To next functionally assess if, similar to FL, t(14;18)+ 
clones from HI also maintained AID activity and kept evolv-
ing with time, we sought to analyze filiations between t(14;18)+ 
cells. The prediction was that if AID were off during clonal 
Figure 3.  AId expression correlates with increasing t(14;18) frequencies in HI. (A) Superposition of t(14;18) frequency (triangles; left y axis) 
and the relative AID expression levels (histograms; right y axis) in PBMC samples from HI (n = 18), FL patient samples (n = 6), and lymphoma cell lines 
(RL7, FL; Daudi and Raji, Burkitt lymphoma) evaluated by real-time quantitative PCR. The expression data were normalized to ABL. As AID expression is 
assumed to be low/negative in naive cells, RT-PCR data are represented relative to the levels obtained in the sorted naive (CD19+CD27IgD+) B cell 
fraction and are considered positive (shaded histograms) above this arbitrary threshold of 1 (dashed line). The results shown were obtained from two 
independent PCRs performed in duplicate (except for clonal FL samples). (B) AID expression is enriched in t(14;18)+ fractions. Comparison of t(14;18) 
detection (+/, as determined by LR-PCR) and AID expression levels (shaded histograms) in isolated B cell subsets (based on CD27 and IgD markers) 
from two HI. The results shown were obtained from one PCR performed in duplicate (except for PBMC samples analyzed two times in duplicate). Data 
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Figure 4.  AId mediates the evolution of t(14;18)+ activated clones in HI. (A and B) Genealogic trees generated from healthy controls (n = 5) and 
exposed individuals (n = 7) for which several molecular subclones derived from the same BCL2/JH junction (labeled A to G in boxes) were obtained. Trees 
are organized based on ICV, including SHM in the Sµ region and CSR on both the expressed (gray boxes, sIgD+; black boxes, sIgD) and the translocated 
(indicated as Sµ or S in boxes) alleles. For most trees, the BCL2/JH junction was already identified at enrollment (blue boxes, ICV information not avail-
able). Six LR-PCR amplicons were obtained from the retrospective PBMC samples (orange boxes) and could be branched in four distinct trees. Stepwise 
accumulation of mutations is indicated by numbers above the branches (+1 to +26). Total mutations, insertions (i), duplications (D), and deletions () are 
summarized at the end of each branch. Shared mutations were used to define putative intermediate or precursor cells (open boxes). The length of the JEM VOL. 206, July 6, 2009  1481
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analyzed Sµ region is indicated below each tree and varied slightly in case of CSR. (C) Sequence analysis of an AID-mediated foreign DNA insertion 
(200 bp from the FAM53B gene, chr 10, in blue) into an Sµ/S switch junction of an activated t(14;18)+ clone from sample #138. (D) Sequence analysis of 
a foreign DNA insertion (161 bp from the SUSD1 gene, chr 9, in blue) into an intra-S2 deletion (64 bp) from an activated t(14;18)+ clone from sample 
#127-b (see clone F-S in A). Numbers refer to germline IGH available from GenBank/EMBL/DDBJ under accession no. NG_001019.
 
This quasisystematic presence of ICV clearly indicates that 
cell division is constantly associated with SHM and/or CSR 
events, and therefore that t(14;18)+ clones have maintained 
AID expression over time. Together with the expression   
of CD10, the presence of ongoing AID-mediated activity 
demonstrates that t(14;18)+ cells in HI indeed represent 
circulating counterparts of “frozen” GC B cells.
In lymphomas, sustained AID activity provides a high pro-
pensity for the acquisition of further oncogenic aberrations. 
This mostly includes CSR-mediated translocations (Ramiro   
et al., 2006), aberrant CSR (Lenz et al., 2007), and the occur-
rence of SHM in non-Ig target genes (Pasqualucci et al., 2001; 
Takizawa et al., 2008). Remarkably, we found that almost 
30% (19 out of 69) of the BCL2/IGH clones tested in the Sµ 
region display unusually large intra-Sµ deletions (up to 763 bp) 
or Sµ tandem duplications interspersed with mutations in AID 
hotspots (Fig. 4; and Fig. S2 A, note e), suggesting that CSR is 
functionally impaired in these clones (Reina-San-Martin et al., 
2003; Lenz et al., 2007). Furthermore, the insertion of an irrel-
evant DNA fragment from a distinct chromosome into a Sµ 
deletion site has been recently observed in a diffuse large B   
cell lymphoma sample, and proposed as a surrogate marker of 
AID-mediated genomic instability and malignant progression 
(Lenz et al., 2007). Strikingly, two of such rare insertion events 
were found in our samples (Fig. 4, C and D). Although probably 
not directly relevant to tumor progression, such events demon-
strate the occurrence of illegitimate AID-mediated events and 
highlight the propensity of some t(14;18)+ clones to withstand a 
complementary oncogenic hit over time.
Collectively, our results clearly demonstrate that the ex-
panded t(14;18)+ clones, which are particularly prominent in 
farmers exposed to pesticides, constitute bona fide FL precur-
sors standing at various stages of tumor progression. Together 
with the recent findings that pesticide exposure is specifically 
associated with a higher risk of t(14;18)+ NHL development 
(Chiu et al., 2006), our data provide the first direct con-
nection between t(14;18) frequency in blood and malignant 
progression. Remarkably, the dynamics of clonal evolution 
observed in HI are strikingly similar to those observed in 
FL (Ruminy et al., 2008) and transformed-FL in diffuse large 
B cell lymphoma (Carlotti et al., 2009), suggesting that the 
selection process operating in malignant clones is already at 
work at early development stages (Fig. 4 and Fig. S8).
The most pressing question in our report is how to assess 
which of those individuals are more likely to develop FL in 
the near future. Some individuals displayed unusual t(14;18) 
frequencies (e.g., # 611, 1 in 1,000 PBMCs) reaching levels 
observed in some FL patients, and others displayed aberrant 
CSR events (e.g., #127-b, ectopic insertions) that indicate a 
predisposition to chromosomal translocations (Lenz et al., 
2007). Our current challenge is to determine how the com-
bined assessment of t(14;18) frequency and surrogate markers 
of malignant progression could be helpful in the identifica-
tion of individuals at “high” risk for transformation to overt 
FL. Besides the identification of at-risk individuals, the pre-
cise understanding of the immunogenic effect described in this 
paper on t(14;18)+ cells might also provide important targets 
for its disruption in preventive approaches (Staudt, 2007; 
Roulland et al., 2008).
MATERIALS AND METHODS
Human samples. A population of 753 farmers/farm workers were included 
in an agricultural cohort that has been previously described (Roulland et al., 
2004). After enrollment (1997–2000), a subset was selected to control for 
potential  confounding  factors  based  on  the  following  criteria:  males,  no 
smoking  history,  and  current  pesticide  applicators  on  open-field  crops. 
Among the 144 individuals matching these criteria, 128 provided DNA/
blood samples (50 ml) for analysis at enrollment (Roulland et al., 2004), 
and 111 participated in the average 9-yr follow up (response rate = 89%; 
Table S2). Large blood samples (250 ml) were obtained from eight of them 
at follow up. As controls, blood samples (50–250 ml) were taken from a 
group of 25 healthy adults issued from a followed-up cohort (Roulland et al., 
2006a), coming from the same geographical area as the exposed group and 
defined as “subjects who have never lived/worked on a farm and were not 
exposed to pesticides.” Large blood samples were also collected from 10 
anonymous bank donors. 2 out of the 10 were screened highly positive for 
t(14;18) frequency and subjected to cell sorting and molecular analysis (see 
B cell isolation…). In addition, 20 tumor biopsies were obtained from FL 
patients at diagnosis (Jager et al., 2000; Ruminy et al., 2008). This study was 
approved by the local ethics committee (Comité Consultatif de Protection 
des Personnes dans la Recherche Biomédicale #99-07, Caen, France), and all 
participants of the study provided their written informed consent.
Pesticide exposure assessment. A face-to-face comprehensive standard-
ized questionnaire was administrated to all enrolled subjects at each time 
point. The interviews included detailed information on agricultural practices 
and pesticide exposure, including the timing and duration of farming activ-
ities, the years of exposure, the personal handling of specific pesticides, the 
average annual number of days of pesticide use on crops, the type of crops 
and average acres grown, the use of personal protective equipment, the na-
ture of chemical classes, and the spraying equipment (Table S2). Exposed 
and control individuals (excluding anonymous blood blank donors) were 
also asked to provide information about sociodemographic characteristics, 
tobacco and alcohol use, dietary habits, medical history, and lifetime occu-
pational exposure (Roulland et al., 2004).
B cell isolation, cell sorting, and FACS analysis. PBMCs were ob-
tained by Ficoll-density gradient centrifugation. For large blood samples, en-
riched B cells were isolated from PBMCs by negative selection using a B cell 
isolation kit (Invitrogen and/or Miltenyi Biotec). The resulting purified B 
cells were then stained for CD19-allophycocyanin (APC) or PE-Cy7 (clone 
HIB-19; BD or eBioscience), IgD-FITC (Invitrogen), IgM-APC (G20-127; 
BD), and CD27-PE (clone O323; eBioscience) mAbs. For control samples, 
the naive (IgD+CD27) and memory (IgD+CD27+, IgDCD27+) B cell 
subsets were isolated by FACS sorting, as previously performed (Roulland   
et al., 2006b). 10 large blood samples from HI (8 from the exposed cohort and 
2 from anonymous blood donors) showing translocation frequencies >105 1482 AGRICULTURAL EXPOSURE IS LINKED TO T(14;18) LYMPHOMAGENESIS | Agopian et al.
Statistical analysis. To examine the relationships between t(14;18) and 
agricultural pesticide use, we first compared the evolution of t(14;18) 
frequency over time among exposed and control groups using the paired 
t test. Normality was tested and rejected because of the skewness of the 
distribution  of  t(14;18)  frequencies.  Relationships  between  t(14;18)  fre-
quency and age were made with the Spearman rank test. For mutation analysis, 
Fisher’s exact test was used to compare Sµ mutation frequencies between 
various B cell subpopulations as compared with FL cells, and the 2 tests 
were used to compare mutation distribution patterns.
Online supplemental material. Fig. S1 shows the restoration of the age 
effect in farmers who stopped agricultural pesticide use at follow up. Fig. S2 
shows the Sµ mutation patterns in normal and t(14;18)+ B cells from HI and 
FL patients. Fig. S3 shows that the majority of t(14;18)+ cells are IgD+M+. 
Fig. S4 illustrates the absolute quantitative RT-PCR strategy to accurately   
measure the BCL2/JH transcripts levels in t(14;18)+ B cells from HI as 
compared with FL. Fig. S5 shows that BCL2/JH transcript expression strictly 
correlates with t(14;18)+ fractions. Fig. S6 depicts a representative cell sort-
ing experiment to isolate peripheral B cell subsets according to CD27, 
CD10, and IgD cell-surface markers, and a diagram showing the positions   
of primers used to characterize BCL2/IGH translocations by SR-PCR 
and/or LR-PCR assays. Fig. S7 shows BCL6 expression in PBMCs and B 
cell subsets from HI with various t(14;18) frequencies. Fig. S8 illustrates the 
two kinds of dynamics than can be modelized from circulating FL precursor 
cells in HI. Table S1 provides a summary of the BCL2/JH polyclonality in 
individuals for which more than one positive amplicon was found. Table S2 
describes the demographic and exposure characteristics of the farmer popula-
tion at enrollment and follow up. Table S3 list the primers used for PCR and 
quantitative RT-PCR reactions. Online supplemental material is available at 
http://www.jem.org/cgi/content/full/jem.20082842/DC1.
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